These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 820102)

  • 21. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin, protamine, and ionized calcium in vitro and in vivo.
    Goto H; Kushihashi T; Benson KT; Kato H; Fox DK; Arakawa K
    Anesth Analg; 1985 Nov; 64(11):1081-4. PubMed ID: 3931505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protamine inhibits formation of the covalent factor IXa-anti-thrombin complex.
    Brecher AS; Roland AR
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):591-6. PubMed ID: 18685444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
    ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Searching for genetic markers--in the fields of forensic medicine and human genetics].
    Ikemoto S
    Nihon Hoigaku Zasshi; 1995 Dec; 49(6):419-31. PubMed ID: 8583686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT).
    Bode AP; Castellani WJ; Hodges ED; Yelverton S
    Thromb Haemost; 1991 Aug; 66(2):213-7. PubMed ID: 1771614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Practical and theoretical considerations in blood group serology of red cells (author's transl)].
    Speiser P; Pausch V; Weirather M
    Wien Klin Wochenschr; 1980; 92(11):379-85. PubMed ID: 6775417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of sialic acid in hemagglutination.
    Khan MY; Zinneman HH
    Am J Clin Pathol; 1970 Nov; 54(5):715-9. PubMed ID: 4990861
    [No Abstract]   [Full Text] [Related]  

  • 29. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
    Teoh KH; Young E; Blackall MH; Roberts RS; Hirsh J
    J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Protaminase activity of plasma and serum in vitro. II.- Electrophoretic study of serum albumin-protamine soluble complexes].
    Blass J; Verriest C; Vicaigne MB; Detruit H; Weiss M
    Pathol Biol (Paris); 1984 Jan; 32(1):40-4. PubMed ID: 6701006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-h absorbed by, and eluted from Oh (Bombay) red blood cells.
    Rodier L; Lopez M; Liberge G; Badet J; Gerbal A; Salmon C
    Biomedicine; 1974 Jul; 21(7):312-6. PubMed ID: 4215471
    [No Abstract]   [Full Text] [Related]  

  • 32. [Study of anti-T-agglutinins in active and inactivated human sera (author's transl)].
    Májský A; Styk B
    Z Immunitatsforsch Exp Klin Immunol; 1975 May; 149(1):1-8. PubMed ID: 127453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An inhibitor to erythrocyte agglutination in bovine albumin preparations.
    Gunson HH; Phillips PK
    Vox Sang; 1975; 28(3):207-17. PubMed ID: 804212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of the anti-D antibody-dependent cellular cytotoxicity against O, Rh-positive (R1R2) erythrocytes by O,Rh-negative (rr) competitor cells.
    Bakács T; Ringwald G; Wedrödy K
    Immunol Lett; 1982 Oct; 5(4):181-6. PubMed ID: 6816721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agglutination of erythrocytes freshly washed with saline solution. Four saline-autoagglutinating sera.
    Allan CJ; Lawrence RD; Shih SC; Williamson KR; Sweatt MA; Taswell HF
    Transfusion; 1972; 12(5):306-11. PubMed ID: 4627338
    [No Abstract]   [Full Text] [Related]  

  • 36. Quantitative haemagglutination. 4. Effect of neuraminidase treatment on agglutination by blood group antibodies.
    Greenwalt TJ; Steane EA
    Br J Haematol; 1973 Aug; 25(2):207-15. PubMed ID: 4199348
    [No Abstract]   [Full Text] [Related]  

  • 37. Titration of antisera to soluble proteins on the basis of an agglutination reaction: conjugation of egg albumin and chicken serum globulin to the incomplete Rh antibody and the subsequent use of Rh-positive cells, sensitized by such conjugated incomplete antibodies, to titrate antisera against egg albumin and chicken globulin.
    COOMBS RR; HOWARD AN; WILD F
    Br J Exp Pathol; 1952 Aug; 33(4):390-7. PubMed ID: 14954111
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative study of protamine chloride and sulphate in relation to the heparin rebound phenomenon.
    Benayahu D; Aronson M
    Thromb Res; 1983 Oct; 32(2):109-14. PubMed ID: 6658709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of human red cells by virus action; agglutination by incomplete Rh antibody.
    CHU CM; COOMBS RR
    Lancet; 1947 Apr; 1(6450):484. PubMed ID: 20294829
    [No Abstract]   [Full Text] [Related]  

  • 40. Quantitative haemagglutination. 6. Relationship of sialic acid content of red cells and aggregation by Polybrene, protamine and poly-L-lysine.
    Greenwalt TJ; Steane EA
    Br J Haematol; 1973 Aug; 25(2):227-37. PubMed ID: 4726903
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.